Ann Marie O'Neill/Linkedin
Aug 22, 2025, 14:36
Join the Thrombosis UK Survey on Severe Thrombophilia: Improve Diagnosis and Treatment Worldwide
Ann Marie O’Neill, a member of The World Thrombosis Day Steering Committee, shared a post on Linkedin:
“Help shape the future of thrombophilia care
Patients living with severe thrombophilia are invited to participate in an important research opportunity.
This research initiative aims to gather critical insights directly from patients to inform global efforts in improving diagnosis, treatment protocols and overall patient outcomes.
The survey is for patients living with severe thrombophilia, including:
- Antithrombin Deficiency
- Protein C Deficiency
- Protein S Deficiency
- Homozygous Factor V Leiden
- Combinations such as Factor V Leiden and Prothrombin 20210.”
Patients living with severe thrombophilia are invited to participate in an important research opportunity developed by Thrombosis UK.
For the survey, check here.
Find similar posts on Hemostasis Today.
-
May 30, 2026, 18:12Khokon Miah Akanda: FDA Approves a First-in-Class Hypertension Drug
-
May 30, 2026, 18:11Alessandro Perrella: It is Not Only about “How High the CRP is”, but “in Which Patient” We are Measuring That Value
-
May 30, 2026, 18:11Jasper van Grunsven: Grateful for Our Rare Disease Team and the Commitment That Drives Our Mission
-
May 30, 2026, 18:10Open Registration for the 2026 Thrombosis Canada Annual Education Conference – Thrombosis Canada
-
May 30, 2026, 18:09Peter Zdziarski: Approval Does Not Mean NovoSeven is 100% Effective or Risk-Free in GT
-
May 30, 2026, 17:07Deepak Yadav: A Privilege to Talk on ESUS at CREST Stroke Conclave 2026
-
May 30, 2026, 16:59Syed A Rizvi: Medical Scoring Systems – Small Numbers, Big Clinical Decisions
-
May 30, 2026, 16:53Timothy “Tim” Sheehan: BNY Wealth Joins the Fight Against Blood Disorders In Support of Hemophilia of Georgia
-
May 30, 2026, 16:51Nouf Bahri: Anticoagulation Initiation for New-Onset Atrial Fibrillation in Critical Illness